Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Daily Feed
  • Analyst Insights & IR
  • Disclosures
    • Semiconductors
    • Energy
    • Robotics
    • Bio & Healthcare
  • Toggle search form

[Disclosure] Alteogen (196170) to Convene Extraordinary General Meeting on December 26 to Vote on Amendments to Articles of Incorporation

Posted on November 18, 2024July 11, 2026 By K-STOCK Editor No Comments on [Disclosure] Alteogen (196170) to Convene Extraordinary General Meeting on December 26 to Vote on Amendments to Articles of Incorporation

Source Fact: Financial Supervisory Service Electronic Disclosure System (DART) / 2024-11-18

Disclosure Type: Decision on Convening of General Shareholders’ Meeting (Extraordinary General Meeting)

💡 3-Second Summary

Alteogen has decided to hold an Extraordinary General Meeting of Shareholders on December 26 to seek shareholder approval for a single agenda item regarding partial amendments to its Articles of Incorporation.

📊 1. [Key Disclosure Content & Major Figures Summary]

  • Date & Time: December 26, 2024, at 09:00 KST
  • Venue: 1st Floor Medium Conference Room, Daejeon Convention Center, 107 Expo-ro, Yuseong-gu, Daejeon
  • Meeting Type: Extraordinary General Meeting of Shareholders (EGM)
  • Key Agenda Item:
    • Agenda Item 1: Partial Amendments to the Articles of Incorporation (Single agenda proposed for submission)
  • Board Resolution Attendance: Both outside directors (2 out of 2) attended the meeting; Auditor was also present.

📈 2. [Expert View: What This Disclosure Means for Investors]

  • Establishing Legal Foundation for Upcoming Strategies: Convening an EGM outside the routine annual schedule to amend corporate bylaws often implies that the company is preparing for an imminent strategic move. In general corporate practices, modifying the Articles of Incorporation serves as a preemptive legal step to facilitate mid-to-long-term expansions, such as adding new business objectives, raising financing limits, or adjusting clauses for structured preferred stock issuances.
  • Limited Short-Term Financial Impact: Since this filing is an administrative notification outlining the scheduling and core agenda of the upcoming shareholder meeting, it does not reflect any immediate structural changes in the company’s core financial earnings or immediate asset value.
  • Investor Caution: The specific clauses and detailed texts of the proposed amendments are not detailed within this initial convocation summary. To evaluate how these modifications might impact future capital adjustments or governance structures, investors should cross-reference the detailed comparison charts that will be made available in the subsequent ‘Notice of EGM’ or ‘Reference Documents’.

📝 Editor’s Comment (by K-STOCK Editor)

Alteogen is setting the stage for its next corporate chapter by calling a year-end EGM to overhaul its bylaws. For a fast-growing biotech pioneer, modifying the foundational corporate charter just months ahead of the regular AGM typically hints at an upcoming material transition—whether that means expanding the authorized share ceiling to secure fresh institutional capital or updating strategic partnership rules. Because these systemic changes require a direct nod from the shareholder base, investors should keep a close eye on the incoming detailed proxy statements to decipher the exact blueprint management plans to execute in the coming year.

📢 Disclaimer & Source Information

Source: This content was structured and newly written based on the official submitted data from the Financial Supervisory Service Electronic Disclosure System (DART).

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

🐂
BULLS
VS
🐻
BEARS

🔥 Bulls vs Bears, drop your analysis in the comments!

Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Samsung Electronics (005930) Approves Massive 3T KRW Buyback & ‘Total Share Cancellation’ to Aggressively Boost Shareholder Value
Next Post: [Disclosure] Alteogen (196170) Sets December 3 as Record Date to Finalize Voting Shareholders for Extraordinary General Meeting

Related Posts

[Disclosure] Alteogen (196170) to List 28,055 Additional Common Shares via Preferred Stock Conversion Disclosures
[Disclosure] Alteogen(196170) to Hold IR at ‘J.P. Morgan 2026 Healthcare Conference’ in San Francisco, U.S. Disclosures
[Disclosure] Alteogen (196170) Signs Exclusive License Agreement with AstraZeneca Subsidiary for ALT-B4 Valued up to USD 600M (KRW 872.9B) Disclosures
[Disclosure] Alteogen (196170) Decides to Table Agenda for Delisting Approval to Relist on KOSPI Market Disclosures
[Disclosure] Alteogen (196170) Receives Advance Notice of Unfaithful Disclosure Corporation Designation Following Two Cases of Mergers and Acquisition Cancellations Disclosures
[Disclosure] Alteogen (196170) to Participate in Korea Investment Week 2025 Presentation Session Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hana Micron (067310) Lifted from Investment Warning Stock Status; Reclassified to Investment Caution on June 9 with Re-designation WarningJuly 8, 2026
  • [Discount Reversal via ADR Listing and Entry into an HBM-Led Super Cycle: SK hynix 000660]July 7, 2026
  • [Discount Narrowing via ADR Listing Momentum and Capital Allocation Diversification: SK Square 402340]July 7, 2026
  • Gaon Cable (000500): Structural Re-rating Driven by North American Infrastructure Expansion and AI Data Center Demand ShocksJuly 7, 2026
  • Hugel (145020): Passing the Trough with Q2 Earnings Surprise and Accelerated U.S. Direct Sales DeploymentJuly 7, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme